Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ · Healthcare
Acadia Pharmaceuticals Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 1.07B | 957.8M | 726.4M | 517.2M | 484.1M | 441.8M | 339.1M | 223.8M | 124.9M | 17.3M | 61,000 | 120,000 | 1.1M | 4.9M | 2.1M | 42.1M | 6.4M |
| Gross Profit | — | — | 684.8M | 507.1M | 473.3M | 431.5M | 327.7M | 211.4M | 115.8M | 14.3M | — | — | — | — | — | — | — |
| Profitability | |||||||||||||||||
| Operating Income | 104.8M | 230.8M | -73.4M | -223.6M | -170.4M | -286.6M | -246.5M | -247.4M | -292.4M | -272.8M | -164.6M | -93.2M | -38.3M | -20.9M | -22.9M | 15.1M | -45.5M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | 391.0M | 226.5M | -61.3M | -216.0M | -167.9M | -281.6M | -235.3M | -245.2M | -289.4M | -271.4M | -164.4M | -92.5M | -37.9M | -20.8M | -22.8M | 15.1M | -45.1M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 170M | 166M | 164M | 162M | 0M | 0M | 155M | 144M | 124M | 121M | 102M | 100M | 91M | 55M | 52M | 39M | 37M |
Acadia Pharmaceuticals Inc. Income Statement — FAQ
Acadia Pharmaceuticals Inc. (ACAD) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACAD's income statement history?
The chart and table above show Acadia Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.